Search Results
Search for other papers by Mojun Zhu in
Google Scholar
PubMed
Search for other papers by Karl R Sorenson in
Google Scholar
PubMed
Search for other papers by Rebecca Liu in
Google Scholar
PubMed
Search for other papers by Bonnie E Gould Rothberg in
Google Scholar
PubMed
Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed
– 33 . ( https://doi.org/10.1097/MPA.0000000000001454 ) Hua J Shi S Xu J Wei M Zhang Y Liu J Zhang B Yu X 2020 Expression patterns and prognostic value of DNA damage repair proteins in resected pancreatic neuroendocrine neoplasms
Search for other papers by Yuanliang Li in
Google Scholar
PubMed
Search for other papers by Yiying Guo in
Google Scholar
PubMed
Search for other papers by Zixuan Cheng in
Google Scholar
PubMed
Search for other papers by Chao Tian in
Google Scholar
PubMed
Search for other papers by Yingying Chen in
Google Scholar
PubMed
Search for other papers by Ruao Chen in
Google Scholar
PubMed
Search for other papers by Fuhuan Yu in
Google Scholar
PubMed
Search for other papers by Yanfen Shi in
Google Scholar
PubMed
Search for other papers by Fei Su in
Google Scholar
PubMed
Search for other papers by Shuhua Zhao in
Google Scholar
PubMed
Search for other papers by Zhizheng Wang in
Google Scholar
PubMed
Search for other papers by Jie Luo in
Google Scholar
PubMed
Department of Integrative Oncology, China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China
Search for other papers by Huangying Tan in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) are a group of rare malignancies with strong heterogeneity, which arise from neuroendocrine cells distributed throughout the body and produce peptide hormone and biogenic amine ( Klöppel 2017
Search for other papers by M C F Mulders in
Google Scholar
PubMed
Search for other papers by Q G de Lussanet de la Sablonière in
Google Scholar
PubMed
Search for other papers by M L F van Velthuysen in
Google Scholar
PubMed
Search for other papers by E M Roes in
Google Scholar
PubMed
Search for other papers by J Hofland in
Google Scholar
PubMed
Search for other papers by W W de Herder in
Google Scholar
PubMed
) Das S & Dasari A 2021 Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences? Current Oncology Reports 23 43. ( https://doi.org/10.1007/s11912-021-01029-7 ) Dasari A Shen C Halperin D Zhao B
Search for other papers by M Cives in
Google Scholar
PubMed
Search for other papers by M Ghayouri in
Google Scholar
PubMed
Search for other papers by B Morse in
Google Scholar
PubMed
Search for other papers by M Brelsford in
Google Scholar
PubMed
Search for other papers by M Black in
Google Scholar
PubMed
Search for other papers by A Rizzo in
Google Scholar
PubMed
Search for other papers by A Meeker in
Google Scholar
PubMed
Search for other papers by J Strosberg in
Google Scholar
PubMed
Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors . Neuroendocrinology 95 120 – 134 . ( doi:10.1159/000335587 ) Fine RL Gulati AP
Inserm U1016, CNRS UMR 8104, Institut Cochin, Université Paris Descartes-Université de Paris, Paris, France
Search for other papers by Chiara Villa in
Google Scholar
PubMed
Department of Neurosurgery, Hôpital Universitaire Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France
Search for other papers by Bertrand Baussart in
Google Scholar
PubMed
Department of Endocrinology, Center for Rare Adrenal Diseases, Hôpital Cochin APHP, Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Lyon 1 University, Villeurbanne, France
Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Lyon, France
Search for other papers by Gerald Raverot in
Google Scholar
PubMed
Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
or related structures’. In most parts, ENDO5 used the 2017 WHO/IARC terminology for neuroendocrine neoplasms to achieve a consistent, reproducible classification of these tumours. It is worth emphasising that the morbidity caused by uncontrolled
Search for other papers by J Hadoux in
Google Scholar
PubMed
Search for other papers by D Malka in
Google Scholar
PubMed
Search for other papers by D Planchard in
Google Scholar
PubMed
Search for other papers by J Y Scoazec in
Google Scholar
PubMed
Search for other papers by C Caramella in
Google Scholar
PubMed
Search for other papers by J Guigay in
Google Scholar
PubMed
Search for other papers by V Boige in
Google Scholar
PubMed
Search for other papers by S Leboulleux in
Google Scholar
PubMed
Search for other papers by P Burtin in
Google Scholar
PubMed
Search for other papers by A Berdelou in
Google Scholar
PubMed
Search for other papers by Y Loriot in
Google Scholar
PubMed
Search for other papers by P Duvillard in
Google Scholar
PubMed
Search for other papers by C N Chougnet in
Google Scholar
PubMed
Search for other papers by D Déandréis in
Google Scholar
PubMed
Search for other papers by M Schlumberger in
Google Scholar
PubMed
Departments of Nuclear Medicine and Endocrine Tumors, Digestive Oncology, Medical Oncology (Thoracic Group), Pathology, Radiology, Centre Antoine Lacassagne, Department of Urologic Oncology, Department of Endocrinology, Department of Biostatistics and Epidemiology, Faculté de Médecine, Gustave Roussy, 114 Rue Edouard Vaillant, F-94800 Villejuif Cedex, France
Search for other papers by I Borget in
Google Scholar
PubMed
Departments of Nuclear Medicine and Endocrine Tumors, Digestive Oncology, Medical Oncology (Thoracic Group), Pathology, Radiology, Centre Antoine Lacassagne, Department of Urologic Oncology, Department of Endocrinology, Department of Biostatistics and Epidemiology, Faculté de Médecine, Gustave Roussy, 114 Rue Edouard Vaillant, F-94800 Villejuif Cedex, France
Search for other papers by M Ducreux in
Google Scholar
PubMed
Search for other papers by E Baudin in
Google Scholar
PubMed
, temozolomide chemotherapy combined with capecitabine and/or bevacizumab was also proposed as an alternative for patients with neuroendocrine neoplasms and high proliferative index ( Welin et al . 2011 ). However, the applicability of this regimen in patients
Search for other papers by Alexa Childs in
Google Scholar
PubMed
Search for other papers by Amy Kirkwood in
Google Scholar
PubMed
Search for other papers by Julien Edeline in
Google Scholar
PubMed
Search for other papers by Tu Vinh Luong in
Google Scholar
PubMed
Search for other papers by Jennifer Watkins in
Google Scholar
PubMed
Search for other papers by Angela Lamarca in
Google Scholar
PubMed
Search for other papers by Doraid Alrifai in
Google Scholar
PubMed
Search for other papers by Phyllis Nsiah-Sarbeng in
Google Scholar
PubMed
Search for other papers by Roopinder Gillmore in
Google Scholar
PubMed
Search for other papers by Astrid Mayer in
Google Scholar
PubMed
UCL Cancer Institute, UCL, London, UK
Search for other papers by Christina Thirlwell in
Google Scholar
PubMed
Search for other papers by Debashis Sarker in
Google Scholar
PubMed
Search for other papers by Juan W Valle in
Google Scholar
PubMed
UCL Cancer Institute, UCL, London, UK
Search for other papers by Tim Meyer in
Google Scholar
PubMed
count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms . British Journal of Cancer 108 1838 – 1845 . ( doi:10.1038/bjc.2013.156 ) Khan MS Kirkwood AA Tsigani T Lowe H Goldstein R Hartley JA
Search for other papers by M Cives in
Google Scholar
PubMed
Search for other papers by J Strosberg in
Google Scholar
PubMed
Search for other papers by S Al Diffalha in
Google Scholar
PubMed
Search for other papers by D Coppola in
Google Scholar
PubMed
. 2009 ). Recently, tumor expression of PD-L1 has been reported in 22% of 32 patients with primarily high-grade, foregut- or hindgut-derived neuroendocrine neoplasms ( Kim et al. 2016 ). In a very heterogeneous cohort of 57 patients with
Search for other papers by Francesca Marini in
Google Scholar
PubMed
Search for other papers by Francesca Giusti in
Google Scholar
PubMed
Donatello Bone Clinic, Villa Donatello Hospital, Sesto Fiorentino, Italy
Search for other papers by Maria Luisa Brandi in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasms (PanNENs) are rare tumors arising from the neuroendocrine cells of the pancreas, accounting for 1–3% of all types of pancreatic tumors ( Bevere et al. 2023 ). They can be classified into two
Department of Oncology, Ryhov County Hospital, Jönköping, Sweden
Search for other papers by Dimitrios Papantoniou in
Google Scholar
PubMed
Search for other papers by Malin Grönberg in
Google Scholar
PubMed
Search for other papers by Espen Thiis-Evensen in
Google Scholar
PubMed
University of Bergen, Deptartment of Clinical Medicine, Bergen, Norway
Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed
Department of Surgery, Ryhov County Hospital, Jönköping, Sweden
Search for other papers by Kalle Landerholm in
Google Scholar
PubMed
Search for other papers by Staffan Welin in
Google Scholar
PubMed
Search for other papers by Eva Tiensuu Janson in
Google Scholar
PubMed
gastroenteropancreatic neuroendocrine neoplasms . Acta Oncologica 60 931 – 941 . ( https://doi.org/10.1080/0284186X.2021.1921262 ) Joish VN Frech F Lapuerta P 2018 Cost-effectiveness analysis of telotristat ethyl for treatment of carcinoid syndrome diarrhea